ES3024937T3 - Vaccine for prophylaxis or treatment of an allergen-driven airway pathology - Google Patents

Vaccine for prophylaxis or treatment of an allergen-driven airway pathology Download PDF

Info

Publication number
ES3024937T3
ES3024937T3 ES19176782T ES19176782T ES3024937T3 ES 3024937 T3 ES3024937 T3 ES 3024937T3 ES 19176782 T ES19176782 T ES 19176782T ES 19176782 T ES19176782 T ES 19176782T ES 3024937 T3 ES3024937 T3 ES 3024937T3
Authority
ES
Spain
Prior art keywords
pertussis
ova
allergen
bpze1
attenuated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES19176782T
Other languages
English (en)
Spanish (es)
Inventor
Camille Locht
Bernard Mahon
Heather Kavanagh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur de Lille
Institut National de la Sante et de la Recherche Medicale INSERM
National University of Ireland Maynooth
Original Assignee
Institut Pasteur de Lille
Institut National de la Sante et de la Recherche Medicale INSERM
National University of Ireland Maynooth
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Pasteur de Lille, Institut National de la Sante et de la Recherche Medicale INSERM, National University of Ireland Maynooth filed Critical Institut Pasteur de Lille
Application granted granted Critical
Publication of ES3024937T3 publication Critical patent/ES3024937T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/099—Bordetella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/544—Mucosal route to the airways

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ES19176782T 2009-04-28 2010-04-26 Vaccine for prophylaxis or treatment of an allergen-driven airway pathology Active ES3024937T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP09305371 2009-04-28

Publications (1)

Publication Number Publication Date
ES3024937T3 true ES3024937T3 (en) 2025-06-05

Family

ID=41057387

Family Applications (2)

Application Number Title Priority Date Filing Date
ES19176782T Active ES3024937T3 (en) 2009-04-28 2010-04-26 Vaccine for prophylaxis or treatment of an allergen-driven airway pathology
ES10715245.6T Active ES2535412T3 (es) 2009-04-28 2010-04-26 Vacuna para la profilaxis o el tratamiento de una patología de las vías respiratorias originada por un alérgeno

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES10715245.6T Active ES2535412T3 (es) 2009-04-28 2010-04-26 Vacuna para la profilaxis o el tratamiento de una patología de las vías respiratorias originada por un alérgeno

Country Status (10)

Country Link
US (7) US20120177688A1 (enExample)
EP (3) EP2424564B1 (enExample)
JP (1) JP5678034B2 (enExample)
CN (1) CN102448490B (enExample)
AU (1) AU2010243708C1 (enExample)
CA (1) CA2759280C (enExample)
DK (1) DK2424564T3 (enExample)
ES (2) ES3024937T3 (enExample)
SG (1) SG175803A1 (enExample)
WO (1) WO2010125014A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0707102B1 (pt) * 2006-03-10 2022-05-31 Institut Pasteur De Lille Composição imunogênica
CA2759280C (en) 2009-04-28 2016-09-20 Inserm (Institut National De La Sante Et De La Recherche Medicale) Vaccine for prophylaxis or treatment of an allergen-driven airway pathology
JP5551774B2 (ja) 2009-06-15 2014-07-16 ナショナル ユニヴァーシティー オブ シンガポール インフルエンザワクチン、組成物、および使用方法
US9415077B2 (en) 2011-11-02 2016-08-16 Institut National De La Sante Et De La Recherche Medicale Effect of an attenuated Bordetella strain against allergic disease
EP2722338A1 (en) 2012-10-17 2014-04-23 INSERM (Institut National de la Santé et de la Recherche Médicale) Novel recombinant Bordetella strains
CN105722530B (zh) 2013-08-16 2020-06-02 罗切斯特大学 用于紧密连接屏障调节的设计肽
US9655959B2 (en) * 2014-10-01 2017-05-23 National University Of Singapore Adenylate cyclase deficient bordetella strains
AU2017242541B2 (en) * 2016-03-29 2022-06-30 Institut National De La Sante Et De La Recherche Medicale (Inserm) Mutant bordetella strains and methods for use
JP6598724B2 (ja) 2016-04-07 2019-10-30 株式会社ジェイテクト ステアリング装置
CA3077428A1 (en) 2017-10-18 2019-04-25 Institut Pasteur De Lille Bordetella strains expressing serotype 3 fimbriae
EP3980054A1 (en) 2019-06-05 2022-04-13 University Of Rochester New designed inhibitors of tight junction formation
EP4208472A1 (en) * 2020-09-04 2023-07-12 Intravacc B.V. Ompa mutations enhance omv production in bordetella pertussis
EP3909971A1 (en) 2020-09-28 2021-11-17 Institute of Life Sciences (ILS) Whole cell livestock vaccine for respiratory diseases

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4883761A (en) 1986-03-25 1989-11-28 The United States Of America As Represented By The Department Of Health And Human Services Pertussis toxin gene: cloning and expression of protective antigen
US5101019A (en) * 1987-05-22 1992-03-31 Takeda Chemical Industries, Ltd. Method for removing pertussis endotoxin, a pertussis toxoid and its production
US6713072B1 (en) 1987-11-02 2004-03-30 Chiron S.R.L. Immunologically active polypeptides with altered toxicity useful for the preparation of an antipertussis vaccine
GB9115332D0 (en) 1991-07-16 1991-08-28 Connaught Lab Manipulation of gene copy number in bordetella
FR2754543B1 (fr) 1996-10-11 1998-12-31 Pasteur Institut Souche de bordetella deficiente dans la production de toxine et exprimant une proteine hydride, liposomes comprenant de la fha et leurs utilisations comme vaccins, et utilisation de la fha pour stimuler les reponses immunitaires
FR2840319B1 (fr) * 2002-05-30 2004-08-20 Pasteur Institut Souches de bordetella rendues deficientes par attenuation genetique
EP1617805A4 (en) * 2003-04-11 2012-07-04 Medimmune Llc METHODS FOR PREVENTING OR TREATING RESPIRATORY CONDITIONS
GB0402131D0 (en) 2004-01-30 2004-03-03 Isis Innovation Delivery method
BRPI0707102B1 (pt) 2006-03-10 2022-05-31 Institut Pasteur De Lille Composição imunogênica
EP2134359A4 (en) 2007-02-23 2010-06-16 Penn State Res Found USE OF A NONVIRULENT BORDETELLA MUTANT AS LIVING VACCINE VECTOR
CN100537767C (zh) * 2007-04-29 2009-09-09 中国药品生物制品检定所 百日咳疫苗保护性抗原的重组表达及其应用
CA2759280C (en) 2009-04-28 2016-09-20 Inserm (Institut National De La Sante Et De La Recherche Medicale) Vaccine for prophylaxis or treatment of an allergen-driven airway pathology
CN101947323B (zh) * 2010-07-26 2013-02-27 北京绿竹生物制药有限公司 一种革兰氏阴性细菌疫苗及其制备方法
US9415077B2 (en) 2011-11-02 2016-08-16 Institut National De La Sante Et De La Recherche Medicale Effect of an attenuated Bordetella strain against allergic disease
EP2722338A1 (en) 2012-10-17 2014-04-23 INSERM (Institut National de la Santé et de la Recherche Médicale) Novel recombinant Bordetella strains
US9655959B2 (en) 2014-10-01 2017-05-23 National University Of Singapore Adenylate cyclase deficient bordetella strains
AU2017242541B2 (en) 2016-03-29 2022-06-30 Institut National De La Sante Et De La Recherche Medicale (Inserm) Mutant bordetella strains and methods for use
US10799573B2 (en) 2016-03-30 2020-10-13 Regents Of The University Of Minnesota Pertussis vaccines and methods of making and using
WO2018213361A1 (en) 2017-05-15 2018-11-22 Vanderbilt University LONG-CIRCULATING ZWITTERIONIC POLYPLEXES FOR siRNA DELIVERY
JP7404226B2 (ja) 2017-07-18 2023-12-25 セラム インスティテュート オブ インディア プライベート リミティド 向上した安定性、高度の免疫原性、及び減少した反応源性を有する免疫原性組成物、並びにその調製プロセス
CA3077428A1 (en) 2017-10-18 2019-04-25 Institut Pasteur De Lille Bordetella strains expressing serotype 3 fimbriae
US12036405B2 (en) 2018-03-23 2024-07-16 The Board Of Regents Of The University Of Oklahoma System and method of electric-induced acoustic tomography for electrotherapy monitoring

Also Published As

Publication number Publication date
US20190358309A1 (en) 2019-11-28
US11819545B2 (en) 2023-11-21
US20200282041A1 (en) 2020-09-10
EP2424564A1 (en) 2012-03-07
JP2012525346A (ja) 2012-10-22
AU2010243708A1 (en) 2011-11-03
EP2424564B1 (en) 2015-02-25
JP5678034B2 (ja) 2015-02-25
CA2759280A1 (en) 2010-11-04
US20210361759A1 (en) 2021-11-25
EP3590532C0 (en) 2025-03-19
SG175803A1 (en) 2011-12-29
US20180085450A1 (en) 2018-03-29
WO2010125014A1 (en) 2010-11-04
US20130183336A1 (en) 2013-07-18
US9839683B2 (en) 2017-12-12
US11110161B2 (en) 2021-09-07
AU2010243708C1 (en) 2014-10-02
CN102448490B (zh) 2015-05-13
AU2010243708B2 (en) 2014-06-12
US20150182614A1 (en) 2015-07-02
US10653765B2 (en) 2020-05-19
CN102448490A (zh) 2012-05-09
CA2759280C (en) 2016-09-20
EP3590532A1 (en) 2020-01-08
US8986709B2 (en) 2015-03-24
ES2535412T3 (es) 2015-05-11
EP2910252A1 (en) 2015-08-26
US20120177688A1 (en) 2012-07-12
EP3590532B1 (en) 2025-03-19
DK2424564T3 (en) 2015-04-27
US10420827B2 (en) 2019-09-24

Similar Documents

Publication Publication Date Title
ES3024937T3 (en) Vaccine for prophylaxis or treatment of an allergen-driven airway pathology
ES2821830T3 (es) Cepas de Bordetella vivas atenuadas como vacuna de dosis única contra la tos ferina
HK40048647A (en) Live attenuated bordetella strains as a single dose vaccine against whooping cough
Mahon et al. Whole-cell pertussis vaccine protects against Bordetella pertussis exacerbation of allergic asthma
HK1226777A1 (en) Live attenuated bordetella strains as a single dose vaccine against whooping cough
HK1226777B (en) Live attenuated bordetella strains as a single dose vaccine against whooping cough
HK1124090B (en) Live attenuated bordetella strains as a single dose vaccine against whooping cough